# SAXAGLIPTIN;METFORMIN HYDROCHLORIDE
> **ANDA205942** · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL PHARMS · Approved 2016-01-21
## Drug
- **FDA Application Number:** ANDA205942
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SAXAGLIPTIN;METFORMIN HYDROCHLORIDE
- **Generic name:** Saxagliptin
- **Active ingredients:** SAXAGLIPTIN; METFORMIN HYDROCHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** AMNEAL PHARMS
- **First approval:** 2016-01-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205942)
---
*AI Analytics · CC0 1.0*